Key takeaways The healthcare sector is coming off a year of underperformance as COVID sales declined, bond yields rose, and new weight-loss therapies caused.
Cancer, obesity, Alzheimer's. In recent years, these therapeutic areas have often captured the spotlight given their sizable patient populations and significant.
Healthcare stock returns have been essentially flat so far in 2023, which may lead some investors to overlook the sector.[1] That could be a mistake given recent.